Evidence map›Paper›PMID 26979757›Full record

SynthesisMedical science monitor : international medical journal of experimental and clinical research2016

Association Between Polymorphism rs678653 in Human Cyclin D1 Gene (CCND1) and Susceptibility to Cancer: A Meta-Analysis.

Xichao Dai, Xizhi Zhang, Buhai Wang, Chaomin Wang, Jingting Jiang, Changping Wu

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Medical science monitor : international medical journal of experimental and clinical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Association betweenBioscience reports · 2018
    Pooled it
  2. Article
  3. Association betweenOncology letters · 2018
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xichao DaiDepartment of Tumor Biological Treatment, The third Affiliated Hospital, Soochow University, Suzhou, Jiangsu, China (mainland).
Xizhi ZhangDepartment of Oncology, Subei People's Hospital of Jiangsu Province, Clinical Medical Medical College of Yangzhou University, Suzhou, Jiangsu, China (mainland).
Buhai WangDepartment of Oncology, Subei People's Hospital of Jiangsu Province, Clinical Medical Medical College of Yangzhou University, Suzhou, Jiangsu, China (mainland).
Chaomin WangDepartment of Oncology, Subei People's Hospital of Jiangsu Province, Clinical Medical Medical College of Yangzhou University, Suzhou, Jiangsu, China (mainland).
Jingting JiangDepartment of Tumor Biological Treatment, The Third Affiliated Hospital, Soochow University, Suzhou, Jiangsu, China (mainland).
Changping WuDepartment of Tumor Biological Treatment, The Third Affiliated Hospital, Soochow University, Suzhou, Jiangsu, China (mainland).
Soochow University · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo assess the association between polymorphism rs678653 in human Cyclin D1 gene (CCND1) and the risk of cancer. MATERIAL/

methodsMultiple biomedical databases were systematically searched. Pooled odds ratios (OR) and 95% confidence intervals (95% CIs) were calculated in the appropriate model.

resultsIn total, 17 case-control studies from 14 articles were included. When combing all available data, no significant association of rs678653 with cancer risk was observed under different genetic models. Stratification by ethnicity also indicated that rs678653 was not correlated with cancer risk in Taiwanese or Indian populations. When stratified by cancer type, no significant association was found between polymorphism rs678653 and digestive tract cancer, head and neck cancer, and gynecological cancer risk.

conclusionsOur comprehensive meta-analysis suggests that the polymorphism rs678653 in CCND1 has no association with cancer risk in different population and disease contexts, indicating that CCND1 rs678653 does not serve a significant biological function in predicting cancer risk.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseCyclin D1FemaleGenes, RecessiveHumansIndiaModels, GeneticNeoplasmsPolymorphism, Single NucleotideTaiwanCCND1 protein, humanCyclin D1

Identifiers

PMID26979757
PMCPMC4798325
OpenAlexW2302184756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.